The type I TGF-β receptor is covalently modified and regulated by sumoylation

被引:112
作者
Kang, Jong Seok [1 ]
Saunier, Elise F. [2 ]
Akhurst, Rosemary J. [2 ,3 ,4 ]
Derynck, Rik [1 ,3 ]
机构
[1] Univ Calif San Francisco, Dept Cell & Tissue Biol, Cell Biol Program, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA
关键词
D O I
10.1038/ncb1728
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Post- translational sumoylation, the covalent attachment of a small ubiquitin-like modifier (SUMO), regulates the functions of proteins engaged in diverse processes. Often associated with nuclear and perinuclear proteins, such as transcription factors, it is not known whether SUMO can conjugate to cell-surface receptors for growth factors to regulate their functions. Here we show that the type I transforming growth factor-beta (TGF-beta) receptor, T beta RI, is sumoylated in response to TGF-beta and that its sumoylation requires the kinase activities of both T beta RI and the type II TGF-beta receptor, T beta RII. Sumoylation of T beta RI enhances receptor function by facilitating the recruitment and phosphorylation of Smad3, consequently regulating TGF-beta-induced transcription and growth inhibition. T beta RI sumoylation modulates the dissemination of transformed cells in a mouse model of T beta RI-stimulated metastasis. T beta RI sumoylation therefore controls responsiveness to TGF-beta, with implications for tumour progression. Sumoylation of cell-surface receptors may regulate other growth factor responses.
引用
收藏
页码:654 / 664
页数:11
相关论文
共 45 条
[1]   SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5 [J].
Benson, Mark D. ;
Li, Qiu-Ju ;
Kieckhafer, Katherine ;
Dudek, David ;
Whorton, Matthew R. ;
Sunahara, Roger K. ;
Iniguez-Lluhi, Jorge A. ;
Martens, Jeffrey R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (06) :1805-1810
[2]   Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity [J].
Bies, J ;
Markus, J ;
Wolff, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) :8999-9009
[3]   Post-translational modification of p53 in tumorigenesis [J].
Bode, AM ;
Dong, ZG .
NATURE REVIEWS CANCER, 2004, 4 (10) :793-805
[4]   RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article) [J].
Buschmann, T ;
Fuchs, SY ;
Lee, CG ;
Pan, ZQ ;
Ronai, Z .
CELL, 2000, 101 (07) :753-762
[5]  
Chen TP, 1998, CANCER RES, V58, P4805
[6]   Novel inactivating mutations of transforming growth factor-β type I receptor gene in head-and-neck cancer metastases [J].
Chen, TP ;
Yan, W ;
Wells, RG ;
Rimm, DL ;
McNiff, J ;
Leffell, D ;
Reiss, M .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (05) :653-661
[7]   Roles of autocrine TGF-β receptor and Smad signaling in adipocyte differentiation [J].
Choy, L ;
Skillington, J ;
Derynck, R .
JOURNAL OF CELL BIOLOGY, 2000, 149 (03) :667-681
[8]   Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene [J].
Dennler, S ;
Itoh, S ;
Vivien, D ;
ten Dijke, P ;
Huet, S ;
Gauthier, JM .
EMBO JOURNAL, 1998, 17 (11) :3091-3100
[9]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[10]   Mechanisms of transforming growth factor-β receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells [J].
Dore, JJE ;
Yao, DY ;
Edens, M ;
Garamszegi, N ;
Sholl, EL ;
Leof, EB .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (03) :675-684